UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Treatment of patients with a history of heparin-induced thrombocytopenia and anti-lepirudin antibodies with argatroban

Journal of thrombosis and thrombolysis, 2005-02, Vol.19 (1), p.65-69

2005

Volltextzugriff (PDF)

Anti-hirudin antibodies alter pharmacokinetics and pharmacodynamics of recombinant hirudin

Thrombosis and haemostasis, 2003-06, Vol.89 (6), p.973-982

2003

Volltextzugriff (PDF)

Chromatographic and electrophoretic applications for the analysis of heparin and dermatan sulfate

Journal of chromatography. B, Biomedical applications, 1996-10, Vol.685 (2), p.223-231

1996

Volltextzugriff (PDF)

Treatment of Patients with a History of Heparin-Induced Thrombocytopenia and Anti-Lepirudin Antibodies with Argatroban

Journal of thrombosis and thrombolysis, 2005-10, Vol.20 (2), p.137-137

2005

Volltextzugriff (PDF)

Long-Term Anticoagulation of Outpatients with Adverse Events to Oral Anticoagulants Using Low-Molecular-Weight Heparin

Seminars in thrombosis and hemostasis, 1997-01, Vol.23 (2), p.167-172

1997

Volltextzugriff (PDF)

Effect of thrombin inhibitors and a glycoprotein IIb/IIIa receptor antagonist in an ex vivo human experimental thrombosis model: Glycoaminoglycans

Seminars in thrombosis and hemostasis, 2001, Vol.27 (5), p.531-536

2001

Volltextzugriff (PDF)

Effect of Thrombin Inhibitors and a Glycoprotein IIb/IIIa Receptor Antagonist in an Ex Vivo Human Experimental Thrombosis Model

Seminars in thrombosis and hemostasis, 2001-10, Vol.27 (5), p.531-536

2001

Volltextzugriff (PDF)

Comparative antithrombotic potencies of direct thrombin inhibitors and low-molecular-weight heparins in an ex vivo human experimental thrombosis model: Glycosaminoglycans: Anticoagulant and Nonanticoagulant Actions

Seminars in thrombosis and hemostasis, 2002, Vol.28 (4), p.379-382

2002

Volltextzugriff (PDF)

Low-Molecular-Weight Heparin and Dermatan Sulfate End Group-Labeled with Tyramine and Fluorescein. Biochemical and Biological Characterization of the Fluorescent-Labeled Heparin Derivative

Seminars in thrombosis and hemostasis, 2002-08, Vol.28 (4), p.343-354

2002

Volltextzugriff (PDF)

Comparative Antithrombotic Potencies of Direct Thrombin Inhibitors and Low-Molecular-Weight Heparins in an Ex Vivo Human Experimental Thrombosis Model

Seminars in thrombosis and hemostasis, 2002-08, Vol.28 (4), p.379-382

2002

Volltextzugriff (PDF)

Anticoagulation in Patients with Heparin-Induced Thrombocytopenia Type II

Seminars in thrombosis and hemostasis, 1997-01, Vol.23 (2), p.189-196

1997

Volltextzugriff (PDF)

Low-molecular-weight heparin and dermatan sulfate end group-labeled with tyramine and fluorescein. Biochemical and biological characterization of the fluorescent-labeled heparin derivative: Glycosaminoglycans: Anticoagulant and Nonanticoagulant Actions

Seminars in thrombosis and hemostasis, 2002, Vol.28 (4), p.343-354

2002

Volltextzugriff (PDF)

Comparison of the Pharmacodynamic and Pharmacokinetic Profiles of Two Low-Molecular-Mass Heparins in Rats

Seminars in thrombosis and hemostasis, 1997-01, Vol.23 (2), p.109-117

1997

Volltextzugriff (PDF)

Measurement of Fluorescent-Labeled LMM-Heparin in Biological Fluids Using Protamine-Linked Microbeads

Seminars in thrombosis and hemostasis, 1997-01, Vol.23 (1), p.23-30

1997

Volltextzugriff (PDF)

Preferential binding of heparin to granulocytes of various species

American journal of veterinary research, 1996-07, Vol.57 (7), p.1016-1020

1996

Volltextzugriff (PDF)

Binding of Fluorescent-Labeled Low Molecular Mass Heparin to Latex Microspheres and to Rat and Human Leukocytes

Seminars in thrombosis and hemostasis, 1994-01, Vol.20 (3), p.227-235

1994

Volltextzugriff (PDF)

Competitive Binding of Low Molecular Mass Heparin-Tyramine Fluorescein-5-Isothiocyanate and Unlabeled Glycosaminoglycans to Leukocytes

Seminars in thrombosis and hemostasis, 1994-01, Vol.20 (3), p.236-244

1994

Volltextzugriff (PDF)

Innovation and Future of Enterprise Information Systems: ERP Future 2012 Conference, Salzburg, Austria, November 2012, Revised Papers

2013., 2013

Volltextzugriff (PDF)

Measuring ERP Usability from the Users' Perspective

Multidimensional Views on Enterprise Information Systems, 2016, Vol.12, p.149-160

2016

Volltextzugriff (PDF)

ERP-End-User Training Through E-Learning: What Should the User Focus On?

Novel Methods and Technologies for Enterprise Information Systems, 2014, Vol.8, p.147-160

2014

Volltextzugriff (PDF)

Critical Success Factors of e-Learning Scenarios for ERP End-User Training

Innovation and Future of Enterprise Information Systems, 2013, Vol.4, p.87-100

2013

Volltextzugriff (PDF)

Is There an Impact of ERP Learners Training Behavior on Acquired Skills

Novel Methods and Technologies for Enterprise Information Systems, 2014, Vol.8, p.161-169

2014

Volltextzugriff (PDF)

The Austrian ERP Market: Systems in Use, System Vendors and Implementation Consultancies

Innovations in Enterprise Information Systems Management and Engineering, 2016, p.95-110

2016

Volltextzugriff (PDF)

Rezensionen

Review of world economics, 1997-12, Vol.133 (4), p.754

1997

Volltextzugriff (PDF)

Rezensionen

Review of world economics, 1997-12, Vol.133 (4), p.754-768

1997

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(23)

Publikationsform

Sprache

Englisch
(25)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Treatment of patients with a history of heparin-induced thrombocytopenia and anti-lepirudin antibodies with argatroban

Anti-hirudin antibodies alter pharmacokinetics and pharmacodynamics of recombinant hirudin

Chromatographic and electrophoretic applications for the analysis of heparin and dermatan sulfate

Treatment of Patients with a History of Heparin-Induced Thrombocytopenia and Anti-Lepirudin Antibodies with Argatroban

Long-Term Anticoagulation of Outpatients with Adverse Events to Oral Anticoagulants Using Low-Molecular-Weight Heparin

Effect of thrombin inhibitors and a glycoprotein IIb/IIIa receptor antagonist in an ex vivo human experimental thrombosis model: Glycoaminoglycans

Effect of Thrombin Inhibitors and a Glycoprotein IIb/IIIa Receptor Antagonist in an Ex Vivo Human Experimental Thrombosis Model

Comparative antithrombotic potencies of direct thrombin inhibitors and low-molecular-weight heparins in an ex vivo human experimental thrombosis model: Glycosaminoglycans: Anticoagulant and Nonanticoagulant Actions

Low-Molecular-Weight Heparin and Dermatan Sulfate End Group-Labeled with Tyramine and Fluorescein. Biochemical and Biological Characterization of the Fluorescent-Labeled Heparin Derivative

Comparative Antithrombotic Potencies of Direct Thrombin Inhibitors and Low-Molecular-Weight Heparins in an Ex Vivo Human Experimental Thrombosis Model

Anticoagulation in Patients with Heparin-Induced Thrombocytopenia Type II

Low-molecular-weight heparin and dermatan sulfate end group-labeled with tyramine and fluorescein. Biochemical and biological characterization of the fluorescent-labeled heparin derivative: Glycosaminoglycans: Anticoagulant and Nonanticoagulant Actions

Comparison of the Pharmacodynamic and Pharmacokinetic Profiles of Two Low-Molecular-Mass Heparins in Rats

Measurement of Fluorescent-Labeled LMM-Heparin in Biological Fluids Using Protamine-Linked Microbeads

Preferential binding of heparin to granulocytes of various species

Binding of Fluorescent-Labeled Low Molecular Mass Heparin to Latex Microspheres and to Rat and Human Leukocytes

Competitive Binding of Low Molecular Mass Heparin-Tyramine Fluorescein-5-Isothiocyanate and Unlabeled Glycosaminoglycans to Leukocytes

Innovation and Future of Enterprise Information Systems: ERP Future 2012 Conference, Salzburg, Austria, November 2012, Revised Papers

Measuring ERP Usability from the Users' Perspective

ERP-End-User Training Through E-Learning: What Should the User Focus On?

Critical Success Factors of e-Learning Scenarios for ERP End-User Training

Is There an Impact of ERP Learners Training Behavior on Acquired Skills

The Austrian ERP Market: Systems in Use, System Vendors and Implementation Consultancies

Rezensionen

Rezensionen

Suchergebnisse filtern